PC, R., M, H., PA, T., M, T., LAT, C., J, E., . . . T, P. (2021). Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of Mycobacterium tuberculosis Growth. ACS omega, 6(3), 2284. https://doi.org/10.1021/acsomega.0c05589
Chicago Style (17th ed.) CitationPC, Ray, et al. "Spirocycle MmpL3 Inhibitors with Improved HERG and Cytotoxicity Profiles as Inhibitors of Mycobacterium Tuberculosis Growth." ACS Omega 6, no. 3 (2021): 2284. https://doi.org/10.1021/acsomega.0c05589.
MLA (9th ed.) CitationPC, Ray, et al. "Spirocycle MmpL3 Inhibitors with Improved HERG and Cytotoxicity Profiles as Inhibitors of Mycobacterium Tuberculosis Growth." ACS Omega, vol. 6, no. 3, 2021, p. 2284, https://doi.org/10.1021/acsomega.0c05589.